(JustPatriots.com)- Israel and South Korea have agreed to work together on vaccine distribution, with South Korea all set to receive a massive 700,000 doses of the Pfizer-BioNTech COVID-19 vaccine from Israel. The shipment of vaccines will be a loan from Israel, and are part of a wider plan to speed up immunizations in the country after a recent surge in infection in the capital city of Seoul.
As of Tuesday, over 1,000 COVID-19 cases had been reported in Seoul, which is the highest number of infections reported since December 2020. It’s also several hundred more cases than the 746 that were announced on Monday, meaning that there is a spike in infections in the country…and it could be a result of the new, more infectious Delta variant.
Israel and South Korea agreed that the same number of vaccines will be given back to Israel, which are already currently on order from Pfizer. The donation will be returned in September or October, and will not require any additional payment.
COVID restrictions and controversies aside, it’s nice to see the world working together, isn’t it?
South Korea has recently struggled to find enough doses to vaccinate enough of its population to reach herd immunity, and supply of the vaccine – particularly Western-developed vaccines that are safer and more effective – is short.
Israel’s new Prime Minister Naftali Bennett said during a press conference in Jerusalem that the vaccines had been loaded onto a plane within hours of the deal being made on Tuesday, and the viability of the vaccines would be verified by South Korea.
He described it as a “win-win” deal and said it was part of an effort to beat the pandemic together.
Israel has long been a world leader in administering the vaccine after quickly obtaining doses and getting to work on vaccinating citizens shortly after the vaccine was approved. Some 55% of the Israeli population has now received the show, and infections are slowing down.
South Korea’s Disease Control and Prevention Agency said that the deal means South Korea can speed up plans to vaccinate employees in sectors where people are regularly in direct contact with other people.